Viewing Study NCT00860535


Ignite Creation Date: 2025-12-24 @ 10:34 PM
Ignite Modification Date: 2026-02-23 @ 3:01 PM
Study NCT ID: NCT00860535
Status: TERMINATED
Last Update Posted: 2015-09-30
First Post: 2009-03-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) View
None Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL) View
Keywords: